Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KRNY | CXII |
|---|---|---|
| Price | $9.11 | $10.65 |
| Change today | ▲ 0.00% | ▲ 0.00% |
| Market cap | $591.51M | $591.61M |
| Return, 3 months | -1.8% | -0.7% |
| Return, year to date | +27.8% | – |
| Return, 1 year | +43.8% | – |
| P/E (TTM) | 16.0 | – |
| P/B | 0.8 | 1.5 |
| P/E percentile vs own 5y | 79th | 0th |
| Dividend yield | 4.83% | – |
| Revenue growth (YoY, latest qtr) | +11.9% | – |
| Net profit growth (YoY) | +6.0% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 20.4% | – |
| Return on equity | 4.8% | – |
| Analyst target vs. price | +17.1% | – |
| Analyst buy share | 67% | – |
| RSI (14) | 35 | 41 |
| 30-day volatility | 19.2% | 9.0% |
| Max drawdown, 1 year | -14.5% | -2.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.